sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks Phthalyl-dl-glutamic acid

Phthalyl-dl-glutamic acid

CAS No.:
6349-98-0
Catalog Number:
AG002LVA
Molecular Formula:
C13H11NO6
Molecular Weight:
277.2295
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
>98.0%(T)(HPLC)
1 week
United States
$220
- +
25g
>98.0%(T)(HPLC)
1 week
United States
$657
- +
Product Description
Catalog Number:
AG002LVA
Chemical Name:
Phthalyl-dl-glutamic acid
CAS Number:
6349-98-0
Molecular Formula:
C13H11NO6
Molecular Weight:
277.2295
MDL Number:
MFCD00023059
IUPAC Name:
2-(1,3-dioxoisoindol-2-yl)pentanedioic acid
InChI:
InChI=1S/C13H11NO6/c15-10(16)6-5-9(13(19)20)14-11(17)7-3-1-2-4-8(7)12(14)18/h1-4,9H,5-6H2,(H,15,16)(H,19,20)
InChI Key:
FEFFSKLJNYRHQN-UHFFFAOYSA-N
SMILES:
OC(=O)CCC(N1C(=O)c2c(C1=O)cccc2)C(=O)O
Properties
Complexity:
436  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
277.059g/mol
Formal Charge:
0
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
277.232g/mol
Monoisotopic Mass:
277.059g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
112A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
0.4  
Literature
Title Journal
Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20110701
Resistance of CD-1 and ogg1 DNA repair-deficient mice to thalidomide and hydrolysis product embryopathies in embryo culture. Toxicological sciences : an official journal of the Society of Toxicology 20110701
Comparative molecular field analysis and comparative molecular similarity indices analysis of thalidomide analogues as angiogenesis inhibitors. Journal of medicinal chemistry 20040422
Properties